FDA Approves Its First Blood Test for Alzheimer's Disease, Pason Pharmaceuticals Facilitates Precision Diagnostic Breakthrough for Alzheimer's Disease！

On May 16, 2025, the U.S. Food and Drug Administration (FDA) officially approved the first blood-based diagnostic technology for Alzheimer's disease (AD)

New diagnostic products in 2015

New diagnostic products for oncology, microbiology, cardiovascular diseases and reproductive medicine will be launched.

Medical Expenses and Health Care Falls as Health Reform Starts

The new reforms are targeting reduction the costs of both medicine and diagnostics

Traditional Chinese Herbal Medicine

For the last decade, Pason has devoted to develop traditional Chinese herbal medicine with new technologies.

Health Official Calls for Real-name HIV Testing

A draft regulation on HIV/AIDS prevention is expected to be handed over to the standing committee of local people's congress of that region for approval.